Bio Elpida Pharmaceutical Support Services
Regulatory IMPD for Cell Based Product

Cell based advanced therapies represent a relatively new field of development in the pharmaceutical industry and as you might be aware, the culture of cells used in Advanced Therapies is subjected to strict regulations and standards.

Regulation EC/1394/2007, published on 13th December 2007, includes Somatic Cell Therapy, Gene Therapy and Tissue Engineering under the term "Advanced Therapies" and defines the used products as "Advanced Therapy Medicinal Products" (ATMP). The requirements for risk management have been tightened. Furthermore full traceability for all starting and raw materials must be warranted.

Hence, thanks to its experience, Bio Elpida proposes to help you with your regulatory matters.

Validation...

3 questions à Yann RENOUARD*, Responsable Validation et Métrologie


What is validation?

Validation is one of the important steps to present a case to the health authorities. Validation allows, with supporting documents, to demonstrate that a method or an analytical method reproducibly leads to the expected results.
According to GMPs: it is a "documented program that provides a high degree of assurance that a specific process, method or system will consistently provide a result that meets predetermined acceptance criteria".

What is it used for?

Validation is used to demonstrate the control of critical aspects of a new process or to demonstrate that significant changes in plant, equipment or process have no impact on the quality of a product. These critical aspects of a new process are defined when performing a risk analysis.

What does Bio Elpida offer in this context?

Bio-Elpida can help you carry out your validations, write the protocols, carry out the operations and save the corresponding reports by following the applicable references (ICH, PE or USP) thanks to a multidisciplinary team.
Bio-Elpida also conducts:
  • Equipment qualifications (IQ, OQ, PQ) according to Annex 15 of the GMP and USP (1058),
  • Analytical validations according to ICH Q2 and USP (1025),
  • And process validations according to Annex 15 of the GMP.
In addition, Bio-Elpida can also support you in the realization of your risk analyzes.

* Yann RENOUARD served as Quality Control Manager in ABBOTT and GSK laboratories. He was also a Process Validation Consultant for SANOFI PASTEUR. Yann RENOUARD joined Bio Elpida in September 2015.



Bio Elpida

Founded in 2009, Bio Elpida is a Biotechnology Contract Manufacturing Company specialised in the development and manufacturing of innovative cell therapies.

The expertise of the company covers 3 areas:
In these areas, Bio Elpida offers services that include:
Bio Elpida is the first French laboratory certified by the French Health Authorities (MSNA) as a Pharmaceutical Company and authorised to manufacture Active Pharmaceutical Ingredients for experimental biological pharmaceuticals.

Bio Elpida - 97 allée Alexandre Borodine - Bâtiment 5 Cèdre 1 - 69800 Saint Priest - FRANCE - Phone: +33 (0)4 78 47 02 70 - Mail: infos@bio-elpida.com
© Bio Elpida. All Rights Reserved - Legal information - Web site by: Estium-Concept
  • Your CMO for
    Innovative Therapy
    SEARCH
    INNOVATE
    ACHIEVE
  • Your CMO for
    Innovative Therapy
    SEARCH
    INNOVATE
    ACHIEVE
  • Your CMO for
    Innovative Therapy
    SEARCH
    INNOVATE
    ACHIEVE
  •  
  •  
  •